Lukasz Hak
Overview
Explore the profile of Lukasz Hak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
158
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wolnik B, Hak L
Expert Opin Drug Saf
. 2013 Jan;
12(2):137-44.
PMID: 23289795
Background: Type 2 diabetes mellitus is characterized by hyperglycaemia. Incidence and progression of microvascular complications have been shown to undergo reduction with lowered glucose levels. Methods: This is an open-label,...
2.
Kinalska I, Bednarska-Chabowska D, Adamiec-Mroczek J, Hak L
ISRN Endocrinol
. 2012 Mar;
2012:625809.
PMID: 22462016
The authors discuss the strategy of use of incretin hormones in type 2 diabetes treatment in the context of cardiovascular complications. The results of the phase III study on human...
3.
Ryba M, Marek N, Hak L, Rybarczyk-Kapturska K, Mysliwiec M, Trzonkowski P, et al.
Cytokine
. 2011 Jun;
55(3):353-61.
PMID: 21641234
The presence of low-grade chronic inflammation is a known feature of long standing diabetes type 1. The association between serum level of several markers of inflammation and severity of DM1...
4.
Ryba M, Hak L, Zorena K, Mysliwiec M, Mysliwska J
Pediatr Endocrinol Diabetes Metab
. 2010 Jun;
16(1):12-6.
PMID: 20529600
Introduction: Quantitative and/or qualitative dysfunctions in a subset of naturally arising regulatory T lymphocytes may have impact on autoimmune disease development, including diabetes type 1. CD62L is a homing receptor...
5.
Trzonkowski P, Debska-Slizien A, Jankowska M, Wardowska A, Carvalho-Gaspar M, Hak L, et al.
Mech Ageing Dev
. 2010 Jan;
131(2):96-104.
PMID: 20060852
Compromised immunity is the hallmark of ageing. Paradoxically, it may be "an ally" in facilitating acceptance of allogeneic grafts in the elderly. In this retrospective study we looked for biomarkers...
6.
Hak L, Mysliwska J, Wieckiewicz J, Szyndler K, Siebert J, Rogowski J
J Interferon Cytokine Res
. 2009 May;
29(6):327-32.
PMID: 19450160
Recently, inflammation has been considered as a risk factor of postoperative atrial fibrillation (PAF). The main purpose of this study was to estimate the connections between occurrence of PAF and...
7.
Mysliwska J, Rutkowska A, Hak L, Siebert J, Szyndler K, Rachon D
Clin Immunol
. 2008 Nov;
130(3):355-64.
PMID: 19008156
We analyzed the relationship between the IVS1-397T > C polymorphism of estrogen receptor alpha gene and inflammatory response of eighty postmenopausal women with an established coronary artery disease (CAD). We...
8.
Zorena K, Mysliwska J, Mysliwiec M, Balcerska A, Hak L, Lipowski P, et al.
Mediators Inflamm
. 2007 Jul;
2007:92196.
PMID: 17641733
The aim of this study was identification of the immunologic markers of the damage to the eye apparatus at early stages of diabetes mellitus (DM) type 1 children. One hundred...
9.
Hak L, Mysliwska J, Wieckiewicz J, Szyndler K, Trzonkowski P, Siebert J, et al.
Immun Ageing
. 2007 May;
4:3.
PMID: 17488493
Background: Viral and bacterial infections have been considered as a risk factor for Coronary Heart Disease (CHD). NK cells, as a first line of defense against those infections, may play...
10.
Mysliwska J, Wieckiewicz J, Hak L, Siebert J, Rogowski J, Szyndler K, et al.
Eur Cytokine Netw
. 2006 Dec;
17(3):181-8.
PMID: 17194638
IL6 gene promoter polymorphisms may influence the outcome of cardiovascular diseases. The aim of our study was to find out whether the -174G>C polymorphism, as well as the IL6 secretory...